Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials-Reference-Cited by-同舟云学术

Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials

Published:2024-04 Issue: Volume:81 Page:43-52
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Milosavljević Filip^ORCID,Molden Prof. Espen,Ingelman-Sundberg Prof. Magnus^ORCID,Jukić Assoc. Prof. Marin M^ORCID

Funder

Science Fund of the Republic of Serbia

Hjärnfonden

Vetenskapsrådet

Publisher

Elsevier BV

Reference43 articles.

1. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials;Arnone;Neurosci Biobehav Rev,2023

2. No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples;Border;Am J Psychiatry,2019

3. Commercial pharmacogenetic-based decision-support tools in psychiatry;Bousman;Lancet Psychiatry,2016

4. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility;Bradley;J Psychiatr Res,2018

5. Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials;Brown;Clin Pharmacol Ther,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.;European Neuropsychopharmacology;2024-11

2. Pharmacogenomic Prescribing Guidelines: Are They Always Useful?;Clinical Pharmacology & Therapeutics;2024-08-05

3. Meta-analyses of pharmacogenetics-guided antidepressant treatment: Reply to milosavljevic;European Neuropsychopharmacology;2024-08

4. A Randomized Controlled Trial Comparing Efficacy and Safety of Antidepressant Monotherapy;Cureus;2024-04-26

5. Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and Treatment;Drug Metabolism and Disposition;2024-04-04